Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Vulvar and Vaginal Atrophy in Menopause
Age: Adult
Dose: Oral – 1-2 mg
Frequency: by mouth once daily
Duration: for 3 weeks, followed by 1 week off
Indication: Prevention of osteoporosis
Dose: Oral – 0.5 mg
Frequency: by mouth once daily
Duration: for 3 weeks, followed by 1 week off

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: No approved pediatric dosage available
Note: No approved pediatric dosage available
Administration
  • May be taken with or without food
  • Take at same time each day
Side Effect

Drug Interaction

Drug NameRisk Factors
CYP1A2 and CYP3A4 inducers (e.g. aminoglutethimide, carbamazepine, phenobarbital, rifampin)
May decrease the effects of estradiol
Hydrocortisone, prednisolone
May enhance the effects when used together

Disease Interaction

Disease NameRisk Factors
Undiagnosed Vaginal Bleeding
May mask serious conditions
Thrombophlebitis or Thromboembolic Disorders
Risk of blood clots

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool (below 30°C) and dry place, away from light & children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.